PYMNTS.com April 1, 2025
The drug development artificial intelligence (AI) startup founded by Google DeepMind co-founder and CEO Demis Hassabis has raised $600 million in its first external funding round.
Isomorphic Labs uses advanced AI models to revolutionize and accelerate drug discovery in different therapeutic areas.
Notably, the startup said its founding was built on AlphaFold, which won Hassabis a Nobel Prize for predicting the structure of virtually all known proteins, solving a half-century biology challenge.
Isomorphic’s goal is to find a cure for all diseases by advancing its AI drug design engine and pushing therapeutic programs into clinical development. Hassabis said the startup is using an interdisciplinary approach.
The funding represents a “significant step forward towards our mission of one day solving all...
Today's Sponsors
Today's Sponsor